← Back to Analyst Consensus 
ITRMF Sell
Iterum Therapeutics plc
Current Price —
Implied Upside —
Analysts 8
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 12, 2026 (17 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Mar 30, 2026 | HC Wainwright & Co. | downgrade | Buy → Neutral | — | 44% |
EPS Estimates
+1y $-0.24
Lo: $-0.24 Hi: $-0.24
1 analysts 0q $-0.20
Lo: $-0.20 Hi: $-0.20
1 analysts 0y $-0.73
Lo: $-0.73 Hi: $-0.73
1 analysts +1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days